Top

BY Devon Carter

Immunotherapy harnesses the natural power of the immune system and enhances its response to cancer. Immune checkpoint inhibitors are the most commonly used type of immunotherapy. There are several types, and they all work by interfering with mechanisms on a cancer cell or on a type of immune cell called T cells.

Recently, a new type of immune checkpoint inhibitor called a LAG-3 inhibitor was approved by the Food and Drug Administration...

Illustration of a tumor cell and a T cell and depictions of relatimab and nivolumab breaking the bond.

BY Sairah Ahmed, M.D. and Elizabeth Shpall, M.D.

Since MD Anderson’s first CAR T cell therapy clinical trial launched in 2015, we’ve cared for hundreds of patients undergoing CAR T cell therapy...

BY Meagan Raeke

Neoadjuvant immunotherapy is an immunotherapy that’s started before surgery. It is almost always followed with additional doses of adjuvant...

BY Meagan Raeke

A cancer diagnosis is never good news, but Paul McKinney knows that his stage III melanoma diagnosis at least came at a “good” time in terms of progress in treating the disease.

Thanks to a clinical trial led by Rodabe Amaria, M.D., Paul received a new immunotherapy combination that completely cleared his cancer after two doses and has allowed him to enjoy retirement cancer-free. Recently, Amaria’s team reported that the immunotherapy...

Paul McKinney and his wife, Mary standing in front of a boat on the water.

BY Cynthia DeMarco

Until she came to MD Anderson, 82-year-old Myrna Youmans had never heard the words “smoldering myeloma.” So, she didn’t know that they described...

BY Cynthia DeMarco

Nodular melanoma is a type of skin cancer that can mimic benign conditions, including blood blisters and acne. It’s also one of the more invasive...

BY Kathy McKay

I’m a nurse, so when I started experiencing pain and swelling in my lower abdomen, I suspected inflammatory bowel disease, or even worse,...

BY Michael Curran, Ph.D.

I’ve always been interested in how to jump-start the immune system. My curiosity led me to train as a postdoc under Jim Allison, Ph.D., in...

BY Carolyn Kleiman

As a senior medical laboratory scientist at MD Anderson, I work behind the scenes to analyze patients’ lab work. My findings play a crucial...

BY Meagan Raeke

Over the last decade, the three-year survival rate for lung cancer has increased dramatically. That means more people are living longer after...